Insight

Dec 20, 2024, 13:52

Biosimilars offer innovative treatment options for cancer care – UICC

Union for International Cancer Control (UICC) posted the following on LinkedIn:

“Biosimilars may be the key to expanding treatment options for cancer patients worldwide. But what are they, and how do they work? Discover the science behind these innovative therapies and their potential to reshape cancer care.

Watch this insightful content, produced with the support of Celltrion Inc., as part of the Rewriting Cancer series produced by BBC StoryWorks and presented by the Union for International Cancer Control (UICC).”

BBC StoryWorks biosimilars cancer cancer innovation cancer treatment Celltrion Inc. global oncology innovative therapies OncoDaily Oncology patient care Rewriting Cancer series UICC

FDA Grants Breakthrough Therapy Designation to Zongertinib (HERNEXEOS) for First-Line Treatment of HER2-Mutant Advanced NSCLC

Hesham ElGhazaly: Global Inclusion in Clinical Trials at Vision Europe 2025

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

Arnaud Lallouette: Servier and IDEAYA Partner to Bring a Promising Uveal Melanoma Treatment

100 Oncologists, One Community: Reflections from the First ESO College Convention